Category: Infectious Diseases

InDevR Licenses Mount Sinai Influenza Antibodies for VaxArray® Neuraminidase Potency Assay
Press Release -

InDevR Licenses Mount Sinai Influenza Antibodies for VaxArray® Neuraminidase Potency Assay

Panel of antibodies developed at Mount Sinai will enable first multiplexed potency assay for tracking neuraminidase in flu vaccines.

Study Reveals a New Method to Address a Major Barrier to Eradicating HIV
Press Release -

Study Reveals a New Method to Address a Major Barrier to Eradicating HIV

Gladstone scientists uncovered a possible strategy to "shock and kill" the virus that hides in cells

Promising Zika Virus Vaccine Candidate
Press Release -

Promising Zika Virus Vaccine Candidate

Memorial Sloan Kettering Cancer Center Support Means Individuals Will Pay Less to Attend Upcoming Infection-Prevention Conference
Press Release -

Memorial Sloan Kettering Cancer Center Support Means Individuals Will Pay Less to Attend Upcoming Infection-Prevention Conference

Pulse Center for Patient Safety Education & Advocacy can offer $10 "People's Price" to attend symposium — while seats last.

Vaxess Technologies Receives Grants Totaling $6 Million to Develop Microneedle Vaccines for Polio, Measles, Rubella
Press Release -

Vaxess Technologies Receives Grants Totaling $6 Million to Develop Microneedle Vaccines for Polio, Measles, Rubella

Grant Funding Will Support Preclinical Development of Two Vaccines Using Vaxess's MIMIX™ Delivery Platform

Rock-Bottom Discount on May 1 Infection Prevention Event Offered to Members of the Public
Press Release -

Rock-Bottom Discount on May 1 Infection Prevention Event Offered to Members of the Public

Pulse CPSEA extends $10 "People's Price" for community members — while seats last.

xTAG® Gastrointestinal Pathogen Panel (GPP) Now Available Through Accu Reference Medical Lab
Press Release -

xTAG® Gastrointestinal Pathogen Panel (GPP) Now Available Through Accu Reference Medical Lab

Same Day Results for 14 of the Most Common Causes of Infectious Diarrhea.

Seattle Biotech SpringStar Awarded Major Research Grant to Combat Zika
Press Release -

Seattle Biotech SpringStar Awarded Major Research Grant to Combat Zika

Seattle Biotech SpringStar awarded NIH Small Business Innovative Research Grant to commercialize groundbreaking trap for Zika carrying mosquitoes

Introducing: InvisiArmor® Medical Residual Hydrogen Peroxide™ Technology for Textiles
Press Release -

Introducing: InvisiArmor® Medical Residual Hydrogen Peroxide™ Technology for Textiles

New Patented technology now offers Healthcare workers the ability to treat and retreat their clothes with Residual Hydrogen Peroxide (RHP) in order to reduce cross-contamination risk from healthcare work clothes. RHP is an eco-friendly and effective way to reduce the bio-burden in your personal space. Once garments are treated, RHP remains effective for 20 launderings against MRSA and other dangerous pathogens. MRSA can live up to 56 days on clothing.

Press Release -

South Florida HIV Grant Recipients Report Important Strides in Research Efforts

Thanks to initial $30,000 grants from The Campbell Foundation, three South Florida researchers have been able to go on to receive additional funding needed to move forward with their HIV/AIDS research.

Press Release -

3rd Euro-Global Conference on Infectious Diseases

OMICS International Conferences invites all the participants from all over the world to attend 'Infectious Diseases Europe 2016' which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.

Press Release -

Global Clostridium Difficile Infections Market Will Soar to $1.5 Billion by 2024 - Market Info Research Report

The global therapeutics and prophylactics market for Clostridium difficile infections (CDIs) will expand more than fourfold from $356.3 million in 2014 to over $1.5 billion by 2024, representing an impressive Compound Annual Growth Rate (CAGR) of 15.8%, according to research and consulting firm GlobalData's report by MarketinfoResearch.com

Seattle Biotech Firm, SpringStar, Steps-Up Fight Against Zika and Dengue Fever
Press Release -

Seattle Biotech Firm, SpringStar, Steps-Up Fight Against Zika and Dengue Fever

The recent outbreaks of Zika and dengue mean that it's all hands on deck at SpringStar, a Seattle biotech firm which manufactures the Trap-N-Kill mosquito trap.

Dr. Robert Geller Has Been Recognized Among the Top in His Industry by the Expert Network©
Press Release -

Dr. Robert Geller Has Been Recognized Among the Top in His Industry by the Expert Network©

The Expert Network celebrates its newest member, Dr. Robert Geller

Press Release -

The Campbell Foundation Tops $10 Million in Donations With Latest Round of Grants

The Campbell Foundation has provided ten Florida nonprofits servicing the HIV/AIDS population with $5,000 grants as part of its End of Year "Holiday Hug" program.